Teva CEO Talks Drug Pricing, Generics, Supply Shortages
Teva Pharmaceuticals CEO Richard Francis reflects on company performance in 2024, drug pricing, getting more drugs to market and supply shortages of the drug Adderall.
He speaks to Bloomberg's Katie Griefeld from the JPMorgan Healthcare Conference.
See omnystudio.com/listener for privacy information.
You May Also Like
Datasets
Visionary
Marketplace All-in-One
Marketplace
The Property Academy Podcast
Opes Partners
The Lucy Ann Lance Show
Cumulus Media Detroit
Honest Ecommerce
Shopify Expert Chase Clymer
Der Bitcoin Podcast
Florian Bruce
CNBC Business News Update
CNBC
Børsmorgen & Økonominyhetene
Finansavisen
Fox Business Hourly Report
FOX News Podcasts
List Building Lifestyle With Igor Kheifets
Igor Kheifets
Datasets
Visionary
Marketplace All-in-One
Marketplace
The Property Academy Podcast
Opes Partners
The Lucy Ann Lance Show
Cumulus Media Detroit
Honest Ecommerce
Shopify Expert Chase Clymer
Der Bitcoin Podcast
Florian Bruce
CNBC Business News Update
CNBC
Børsmorgen & Økonominyhetene
Finansavisen
Fox Business Hourly Report
FOX News Podcasts
List Building Lifestyle With Igor Kheifets
Igor Kheifets
Community discussion